All articles tagged with #ipilimumab
A man with glioblastoma experienced a complete disappearance of his tumor after receiving an experimental immunotherapy drug, ipilimumab, in a trial, offering new hope for this aggressive cancer.
A 40-year-old man with terminal glioblastoma has become cancer-free after a groundbreaking immunotherapy trial using ipilimumab before standard treatment, offering new hope for this aggressive brain cancer.
A groundbreaking clinical trial using the immunotherapy drug ipilimumab shows promise in treating glioblastoma, the deadliest brain cancer, with one patient remaining cancer-free over two years after treatment, offering new hope for patients.